Paving the Way for Biomedical Innovation

The Frederick National Laboratory is meeting the nation’s most urgent biomedical research needs and serves as a national and global resource for the scientific community. 

Clinical Monitoring Research Program to support clinical study exploring alternative to cervical cancer screening

A new U.S. clinical trial will evaluate whether an at-home, self-collection technique to screen for cervical cancer is as...
Cancer Research

RAS Initiative partnership identifies novel therapeutic, improves predominant drug discovery model

A team from the National Cancer Institute RAS Initiative and collaborators at Lawrence Livermore National Laboratory and...
HIV/AIDS Research

Study establishes measurement for factor affecting immune response to HIV

HIV ravages the immune system in people who acquire it, but not everyone is affected equally. In some of these individuals...
Drug Development

Biopharmaceutical Development Program embarks on new work for targeted cancer therapy

The Biopharmaceutical Development Program (BDP) has entered a new area of investigational cancer treatment development: an...

‘What a scientist looks like’: Women in science describe adversity and success 

There are many paths for women to travel to find success in science. That was a crucial theme conveyed by the four panelists...

Specific retinoid shrinks immune checkpoint-resistant lung cancers in mice

Frederick National Laboratory researchers identified a vitamin A derivative (retinoid) that when combined with a standard...
HIV/AIDS Research

New drug to treat HIV might also be used to block infection altogether

Research led by the Frederick National Laboratory for Cancer Research (FNL) and Gilead Sciences shows the potential for a new...
What is this?

Representative picture of colon of infected RM- that was infused with engineered CD8+ T cells to reduce the viral load. The Tissue Analysis and Retroviral Protein Core provides state-of-the-art tissue analysis capabilities.

Information
Initiative

Center for Innovation and Strategic Partnerships

We bring the Frederick National Laboratory’s distinct capabilities to the broader research community to help solve urgent problems in biomedical research.
156
Cooperative Research and Development Agreements and CRADA amendments to enable and extend research projects between FNL scientists and external investigators.
Initiative

RAS Initiative

The RAS Initiative mobilizes the cancer research community to develop ways to treat cancers driven by the mutant RAS gene in an open model of collaboration among government, academic, and industry researchers.
220,000
People per year in the U.S. are diagnosed with cancers caused by KRAS mutations.
What is this? Surface representation of the structure of an oncogenic mutant of KRAS in complex with RAS-binding domains of RAF1 Kinase. The GMPPNP bound to oncogenic KRAS mutant is shown in ball-and-stick representation.
Information

Our Passion is Infectious

Shape Your Career

Work with the best of the best biomedical researchers and investigators. Be a part of groundbreaking solutions that benefit public health throughout the world. And, enjoy some of the best benefits in the region. We are looking for smart, passionate problem solvers for benchwork, data science, manufacturing, and more.